Pertussis in Southeast Asia: country-level burden and recommendations from the Global Pertussis Initiative
- PMID: 39906191
- PMCID: PMC11791295
- DOI: 10.1016/j.ijregi.2024.100559
Pertussis in Southeast Asia: country-level burden and recommendations from the Global Pertussis Initiative
Abstract
The Global Pertussis Initiative met in March 2024 to discuss the burden of pertussis and prevention efforts in six Southeast Asian countries: Cambodia, Indonesia, Malaysia, Singapore, Thailand, and Vietnam. Except for Cambodia, pertussis is a notifiable disease; data accuracy varies within and between countries. Most cases in the region are diagnosed based on clinical suspicion. Whole-cell and acellular pertussis combination vaccines are available, but the composition differs between countries. Immunization against pertussis is well-established, but policies regarding boosting vary. Vaccination in pregnancy represents a still-neglected opportunity to protect infants. The Global Pertussis Initiative recommends enacting vaccination in pregnancy in countries without and increasing coverage in countries with policies already in place. There is a need to correct the misperception that pertussis affects children exclusively and that childhood vaccines provide lifelong protection. Education is key to widespread understanding of the threat of pertussis and removing barriers to vaccination in Southeast Asia.
Keywords: Global Pertussis Initiative; Immunization; Pertussis; Southeast Asia; Surveillance; Vaccine.
© 2025 The Authors.
Conflict of interest statement
The authors are scientific experts and, as such, received honoraria for their participation in this live meeting from Sanofi. In addition, U.H. was a member of the Collaboration of European Experts on Pertussis Awareness Generation (CEEPAG; he was a group member until 2021) and has received honoraria for participation in previously associated live meetings from Sanofi, USA, and Sanofi, France, respectively, as well as receiving honoraria for educational activities from GSK, Pfizer, MSD, Sanofi, and InfectoPharm. R.M. has received honoraria for educational activities from MSD and Sanofi. C.H.W.K. has received honoraria for attending meetings sponsored by Sanofi, GSK Biologicals SA, MSD, and Novartis Vaccines. T.Q.T. has received grants from Merck and Sanofi, personal fees from GSK Biologicals and Sanofi, and honoraria from Sanofi. K.F. has also previously received honoraria from Sanofi. The authors declare no other conflict of interest.
Similar articles
-
Pertussis in Asia: Recent country-specific data and recommendations.Vaccine. 2022 Feb 16;40(8):1170-1179. doi: 10.1016/j.vaccine.2021.12.004. Epub 2022 Jan 22. Vaccine. 2022. PMID: 35074239
-
Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update.Vaccine. 2018 Nov 19;36(48):7270-7275. doi: 10.1016/j.vaccine.2018.10.028. Epub 2018 Oct 15. Vaccine. 2018. PMID: 30337176 Review.
-
Maternal immunization: trends in South and Southeast Asian countries.J Matern Fetal Neonatal Med. 2022 Dec;35(25):8372-8381. doi: 10.1080/14767058.2021.1974389. Epub 2021 Sep 13. J Matern Fetal Neonatal Med. 2022. PMID: 34517746 Review.
-
The need for pertussis vaccination among older adults and high-risk groups: a perspective from advanced economies of the Asia Pacific region.Expert Rev Vaccines. 2021 Dec;20(12):1603-1617. doi: 10.1080/14760584.2021.1990759. Epub 2021 Nov 22. Expert Rev Vaccines. 2021. PMID: 34734556
-
Country-Specific Data and Priorities for Pertussis in Latin America: Recent Findings From the Global Pertussis Initiative.Open Forum Infect Dis. 2025 May 13;12(5):ofaf154. doi: 10.1093/ofid/ofaf154. eCollection 2025 May. Open Forum Infect Dis. 2025. PMID: 40365078 Free PMC article. Review.
Cited by
-
Analysis of strategies China should adopt in response to global pertussis trends.Hum Vaccin Immunother. 2025 Dec;21(1):2509416. doi: 10.1080/21645515.2025.2509416. Epub 2025 May 22. Hum Vaccin Immunother. 2025. PMID: 40401645 Free PMC article.
-
Protective antibodies against diphtheria, tetanus, and pertussis following revaccination in children and young adults having undergone haematopoietic stem cell transplantation.BMC Res Notes. 2025 Jul 1;18(1):251. doi: 10.1186/s13104-025-07332-x. BMC Res Notes. 2025. PMID: 40597356 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous